Indee Labs Status
The company received AUD 500,000 of grant funding from NSW State Government on August 8, 2018.
Developer of gene delivery hardware designed to unlock gene-modified cell therapy for the masses. The company's hardware is based on microfluidic technology that uses microfluidic vortex shedding to enable fast processing of small and large volumes of human primary immune cells and it can achieve high yield with a simple workflow and does not change human primary immune cell activation or exhaustion profiles, enabling efficient development and scalable manufacturing of gene-modified cell therapies.
Year Founded
2015
Employees
9
RevenueFY 2018
$310 K
General Information
-
Website
-
Business Status
Generating Revenue/Not Profitable
-
Ownership Status
Privately Held (backing)
-
Financing Status
Venture Capital-Backed
Indee Labs News and Updates
Indee Labs Partners With Monomer Bio to Automate Engineered ...
PR Newswire | December 1, 2022
Ernst Calls on White House to Reinstate Ban on 'Risky Research'
Cedar Valley Daily Times | November 29, 2022
Indee Labs Awarded $2M Contract to Scale up and out Hydropore ...
PR Newswire | November 2, 2022
Producers Guild Screeners Going Digital (Exclusive)
Hollywood Reporter | November 2, 2022
At least Liz Truss’s dull delivery skills will make oncoming crises seem less dramatic
The Guardian | September 6, 2022
MUSC immunology researcher receives SBIR grant to push ...
Medical University of South Carolina | August 22, 2022
Indee Labs's Feed
Indee Labs's Verticals
Indee Labs Primary Industry Sector / Group / Code
Indee Labs's Trends
Indee Labs Metrics
Twitter Followers
Headquarters
-
HQ Address Line 1Bonneville Labs
-
HQ Address Line 2626 Bancroft Way, Suite A
-
HQ CityBerkeley
-
HQ State/ProvinceCalifornia
-
HQ Post Code94710
-
HQ CountryUnited States
Indee Labs's Keywords
Add a review